Concepedia

Sheri A. Kostelny

SA

4

Publications

362

Citations

4

H-Index

1992

Active since

Affiliations

PDL BioPharma (United States)(Current)

University of Iowa

Sheri A. Kostelny is an author at PDL BioPharma (United States) specializing in cancer research, medicine, and t cell immunity.

Top concepts

Publications per year

1992–2001

4

Publications

4

Formation of a bispecific antibody by the use of leucine zippers

Sheri A. Kostelny, Michael S. Cole, J. Yun Tso · The Journal of Immunology · 1992 · 210 citations · Full text

The role of T cell activation in anti-CD3 x antitumor bispecific antibody therapy.

George J. Weiner, Sheri A. Kostelny, J R Hillstrom et al. · The Journal of Immunology · 1994 · 66 citations · Full text

, , +16

Humanization and characterization of the anti-HLA-DR antibody 1D10

Sheri A. Kostelny, Brian K. Link, J. Yun Tso et al. · International Journal of Cancer · 2001 · 58 citations · Full text

Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms

Brian K. Link, Sheri A. Kostelny, Michael S. Cole et al. · International Journal of Cancer · 1998 · 28 citations · Full text

Rows per page

1–4 of 4